According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements regarding the Company’s:

• statements it was a “one-stop-shop” for cancer testing because it did not offer the most technologically advanced NGS tests, which led to a significant decrease in revenue as current and prospective customers went elsewhere for their testing needs;
• costs, which were not fixed because the Company needed to hire additional employees to process more complex customized testing demanded by customers utilizing the Company’s outdated portfolio of tests, leading to operational challenges, decrease lab efficiency, and increased testing turnaround times; and
• thus, the Company violated federal healthcare laws and regulations related to fraud, waste, and abuse

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.